ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,633.91
      1.02%
      US Tech 100
      20,114.80
      -0.02%
      Dow Jones
      39,721.36
      1.09%
      Brent Oil
      84.995
      -0.06%
      Bitcoin
      58,458.72
      1.22%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kazia Therapeutics Ltd (KZIA)

      7. Kazia Therapeutics Ltd (KZIA) News

      KZIA

      Kazia Therapeutics (KZIA)

      Kazia Therapeutics Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KZIA
      DateTimeSourceHeadlineSymbolCompany
      12:30PMiHub NewswireFeaturedECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch
      08/20/20206:03AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      08/20/20205:30AMPR Newswire (US)US FDA Awards Fast Track Designation (FTD) to Paxalisib for GlioblastomaNASDAQ:KZIAKazia Therapeutics Ltd
      08/07/202010:30AMPR Newswire (US)US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPGNASDAQ:KZIAKazia Therapeutics Ltd
      08/07/20206:12AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      08/07/20205:30AMPR Newswire (US)US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPGNASDAQ:KZIAKazia Therapeutics Ltd
      06/22/202010:30AMPR Newswire (US)Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both DrugsNASDAQ:KZIAKazia Therapeutics Ltd
      06/22/20205:30AMPR Newswire (US)Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both DrugsNASDAQ:KZIAKazia Therapeutics Ltd
      06/01/202010:30AMPR Newswire (US)Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival SignalNASDAQ:KZIAKazia Therapeutics Ltd
      06/01/20205:30AMPR Newswire (US)Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival SignalNASDAQ:KZIAKazia Therapeutics Ltd
      04/07/20208:00AMPR Newswire (US)Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma StudyNASDAQ:KZIAKazia Therapeutics Ltd
      12/11/201910:00AMPR Newswire (US)Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastom...NASDAQ:KZIAKazia Therapeutics Ltd
      12/11/20195:00AMPR Newswire (US)Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastom...NASDAQ:KZIAKazia Therapeutics Ltd
      11/25/201910:00AMPR Newswire (US)Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO ConferenceNASDAQ:KZIAKazia Therapeutics Ltd
      11/25/20195:00AMPR Newswire (US)Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO ConferenceNASDAQ:KZIAKazia Therapeutics Ltd
      11/13/20196:11AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      11/13/20196:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      11/12/20196:22AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      11/01/20191:11PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/31/20196:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/28/201911:21AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/21/20198:08AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:KZIAKazia Therapeutics Ltd
      10/15/20196:43AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      09/30/20196:17AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      09/26/20196:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      09/13/20198:00AMPR Newswire (US)Kazia wins ANZLF Trans-Tasman Innovation & Growth Award and reports new data from clinical trial in childhood brain cancerNASDAQ:KZIAKazia Therapeutics Ltd
      09/12/20199:10AMPR Newswire (US)St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now UnderwayNASDAQ:KZIAKazia Therapeutics Ltd
      09/12/20196:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      08/23/20196:22AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      08/13/20196:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
       Showing the most relevant articles for your search:NASDAQ:KZIA

      Your Recent History

      BIT
      CSNKY
      Exchange Traded
      Delayed Upgrade Clock